Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Women With Severe Aortic Stenosis: The RHEIA Trial
Open Access
- 6 January 2026
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (1) , e047196
Abstract
Background: In the RHEIA (Randomized Research in Women All Comers With Aortic Stenosis) trial, the incidence of the primary end point of death, stroke, or rehospitalization at 1 year was lower with transcatheter aortic valve implantation (TAVI) than with surgical aortic valve replacement. The objective of this substudy was to compare echocardiographic findings in women with severe aortic stenosis following surgical aortic valve replacement or TAVI. Methods: At 48 European centers, 443 women underwent randomization 1:1, and 420 were treated as randomized. Echocardiograms were available in 356 patients and were analyzed by a core laboratory. Results: Rates of or greater moderate paravalvular regurgitation was low (P =1) was low and not different between groups. Valve hemodynamics were stable at 1 year. The rate of residual left ventricular hypertrophy (45.3 versus 28.6%; P =0.004) at 1 year was significantly higher with TAVI, whereas the rate of right ventricular systolic dysfunction (14.5 versus 40.7%; P P =0.001) were better with TAVI. Conclusions: Among women with severe aortic stenosis, both TAVI and surgical aortic valve replacement achieve excellent valve hemodynamic results with low and similar rates of moderate or greater paravalvular regurgitation or severe patient–prosthesis mismatch. Surgical aortic valve replacement was associated with lower gradients and more pronounced regression of left ventricular hypertrophy, whereas TAVI was associated with better right ventricular systolic function and evolution of cardiac damage stage. REGISTRATION: URL: https://clinicaltrials.gov/study/NCT04160130 ; Unique Identifier: NCT04160130.Keywords
This publication has 36 references indexed in Scilit:
- Patterns of aortic valve replacement in Europe and adoption by sexInternational Journal of Cardiology, 2024
- Unique Aspects of Women's Valvular Heart Diseases: Impact for Diagnosis and TreatmentCJC Open, 2023
- Evolution and Prognostic Impact of Cardiac Damage After Aortic Valve ReplacementJACC, 2022
- Outcomes 2 Years After Transcatheter Aortic Valve Replacement in Patients at Low Surgical RiskJACC, 2021
- Rationale and design of a prospective, randomized, controlled, multicenter study to evaluate the safety and efficacy of transcatheter heart valve replacement in female patients with severe symptomatic aortic stenosis requiring aortic valve intervention (Randomized researcH in womEn all comers wIth Aortic stenosis [RHEIA] trial)American Heart Journal, 2020
- Guidelines for the Evaluation of Valvular Regurgitation After Percutaneous Valve Repair or ReplacementJournal of the American Society of Echocardiography, 2019
- Female-specific survival advantage from transcatheter aortic valve implantation over surgical aortic valve replacement: Meta-analysis of the gender subgroups of randomised controlled trials including 3758 patientsInternational Journal of Cardiology, 2018
- Does mild paravalvular regurgitation post transcatheter aortic valve implantation affect survival? A meta‐analysisCatheterization and Cardiovascular Interventions, 2017
- Usefulness of the Valvuloarterial Impedance to Predict Adverse Outcome in Asymptomatic Aortic StenosisJACC, 2009
- Echocardiographic Imaging in Clinical Trials: American Society of Echocardiography Standards for Echocardiography Core LaboratoriesJournal of the American Society of Echocardiography, 2009